Cargando…
Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles
Herbal chemicals with a long history in medicine have attracted a lot of attention. Flavonolignans and flavonoids are considered as two classes of the above-mentioned compounds with different functional groups which exhibit several therapeutic capabilities such as antimicrobial, anti-inflammatory, a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383758/ https://www.ncbi.nlm.nih.gov/pubmed/37514130 http://dx.doi.org/10.3390/pharmaceutics15071944 |
_version_ | 1785080989755637760 |
---|---|
author | Ranjbar, Shahla Emamjomeh, Abbasali Sharifi, Fatemeh Zarepour, Atefeh Aghaabbasi, Kian Dehshahri, Ali Sepahvand, Azadeh Mohammadi Zarrabi, Ali Beyzaei, Hamid Zahedi, Mohammad Mehdi Mohammadinejad, Reza |
author_facet | Ranjbar, Shahla Emamjomeh, Abbasali Sharifi, Fatemeh Zarepour, Atefeh Aghaabbasi, Kian Dehshahri, Ali Sepahvand, Azadeh Mohammadi Zarrabi, Ali Beyzaei, Hamid Zahedi, Mohammad Mehdi Mohammadinejad, Reza |
author_sort | Ranjbar, Shahla |
collection | PubMed |
description | Herbal chemicals with a long history in medicine have attracted a lot of attention. Flavonolignans and flavonoids are considered as two classes of the above-mentioned compounds with different functional groups which exhibit several therapeutic capabilities such as antimicrobial, anti-inflammatory, antioxidant, antidiabetic, and anticancer activities. Based on the studies, high hydrophobic properties of the aforementioned compounds limit their bioavailability inside the human body and restrict their wide application. Nanoscale formulations such as solid lipid nanoparticles, liposomes, and other types of lipid-based delivery systems have been introduced to overcome the above-mentioned challenges. This approach allows the aforementioned hydrophobic therapeutic compounds to be encapsulated between hydrophobic structures, resulting in improving their bioavailability. The above-mentioned enhanced delivery system improves delivery to the targeted sites and reduces the daily required dosage. Lowering the required daily dose improves the performance of the drug by diminishing its side effects on non-targeted tissues. The present study aims to highlight the recent improvements in implementing lipid-based nanocarriers to deliver flavonolignans and flavonoids. |
format | Online Article Text |
id | pubmed-10383758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103837582023-07-30 Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles Ranjbar, Shahla Emamjomeh, Abbasali Sharifi, Fatemeh Zarepour, Atefeh Aghaabbasi, Kian Dehshahri, Ali Sepahvand, Azadeh Mohammadi Zarrabi, Ali Beyzaei, Hamid Zahedi, Mohammad Mehdi Mohammadinejad, Reza Pharmaceutics Review Herbal chemicals with a long history in medicine have attracted a lot of attention. Flavonolignans and flavonoids are considered as two classes of the above-mentioned compounds with different functional groups which exhibit several therapeutic capabilities such as antimicrobial, anti-inflammatory, antioxidant, antidiabetic, and anticancer activities. Based on the studies, high hydrophobic properties of the aforementioned compounds limit their bioavailability inside the human body and restrict their wide application. Nanoscale formulations such as solid lipid nanoparticles, liposomes, and other types of lipid-based delivery systems have been introduced to overcome the above-mentioned challenges. This approach allows the aforementioned hydrophobic therapeutic compounds to be encapsulated between hydrophobic structures, resulting in improving their bioavailability. The above-mentioned enhanced delivery system improves delivery to the targeted sites and reduces the daily required dosage. Lowering the required daily dose improves the performance of the drug by diminishing its side effects on non-targeted tissues. The present study aims to highlight the recent improvements in implementing lipid-based nanocarriers to deliver flavonolignans and flavonoids. MDPI 2023-07-14 /pmc/articles/PMC10383758/ /pubmed/37514130 http://dx.doi.org/10.3390/pharmaceutics15071944 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ranjbar, Shahla Emamjomeh, Abbasali Sharifi, Fatemeh Zarepour, Atefeh Aghaabbasi, Kian Dehshahri, Ali Sepahvand, Azadeh Mohammadi Zarrabi, Ali Beyzaei, Hamid Zahedi, Mohammad Mehdi Mohammadinejad, Reza Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles |
title | Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles |
title_full | Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles |
title_fullStr | Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles |
title_full_unstemmed | Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles |
title_short | Lipid-Based Delivery Systems for Flavonoids and Flavonolignans: Liposomes, Nanoemulsions, and Solid Lipid Nanoparticles |
title_sort | lipid-based delivery systems for flavonoids and flavonolignans: liposomes, nanoemulsions, and solid lipid nanoparticles |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383758/ https://www.ncbi.nlm.nih.gov/pubmed/37514130 http://dx.doi.org/10.3390/pharmaceutics15071944 |
work_keys_str_mv | AT ranjbarshahla lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT emamjomehabbasali lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT sharififatemeh lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT zarepouratefeh lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT aghaabbasikian lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT dehshahriali lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT sepahvandazadehmohammadi lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT zarrabiali lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT beyzaeihamid lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT zahedimohammadmehdi lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles AT mohammadinejadreza lipidbaseddeliverysystemsforflavonoidsandflavonolignansliposomesnanoemulsionsandsolidlipidnanoparticles |